共 50 条
Innovative designs of point-of-care comparative effectiveness trials
被引:11
|作者:
Shih, Mei-Chiung
[1
]
Turakhia, Mintu
[2
,5
]
Lai, Tze Leung
[3
,4
]
机构:
[1] VA Palo Alto Cooperat Studies Program Coordinatin, Mountain View, CA 94043 USA
[2] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[5] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA
基金:
美国国家科学基金会;
美国国家卫生研究院;
关键词:
Adaptive design;
Anticoagulants;
Comparative effectiveness;
Point-of-care trials;
Pragmatic trials;
Shared decision making;
SHARED DECISION-MAKING;
CARDIAC-RESYNCHRONIZATION THERAPY;
2-STAGE RANDOMIZATION DESIGNS;
CLINICAL-TRIALS;
WARFARIN;
DABIGATRAN;
NEED;
D O I:
10.1016/j.cct.2015.06.014
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
One of the provisions of the health care reform legislation in 2010 was for funding pragmatic clinical trials or large observational studies for comparing the effectiveness of different approved medical treatments, involving broadly representative patient populations. After reviewing pragmatic clinical trials and the issues and challenges that have made them just a small fraction of comparative effectiveness research (CER), we focus on a recent development that uses point-of-care (POC) clinical trials to address the issue of "knowledge-action gap" in pragmatic CER trials. We give illustrative examples of POC-CER trials and describe a trial that we are currently planning to compare the effectiveness of newly approved oral anticoagulants. We also develop novel stage-wise designs of information-rich POC-CER trials under competitive budget constraints, by using recent advances in adaptive designs and other statistical methodologies. Published by Elsevier Inc.
引用
收藏
页码:61 / 68
页数:8
相关论文